The upcoming edition of the Delhi Half Marathon, a World Athletics Gold Label Road Race, will feature some globally acclaimed runners clashing for top honours in the Indian capital on Sunday.
New Delhi [India], October 18: Luxury residential is on the uptick in the Indian realty market. According to a JLL report, Delhi-NCR contributed 64% of the total launches of luxury residential among the top seven cities in the first half of 2024. The region is witnessing a rise in demand for
New Delhi [India], October 18: Best Agrolife Limited (BSE: 539660, NSE: BESTAGRO), amongst India's leading agrochemicals manufacturers, announced its unaudited financial results for the quarter and half year ended September 30th, 2024, in the Board meeting held on 18th October, 2024.
Two-time Olympic gold medallist Valarie Allman, the International Event Ambassador for the Delhi Half Marathon 2024, shared her excitement to see the massive participation for the upcoming World Athletics Gold Label Road Race.
Speaking at the 19th International Conference of Drug Regulatory Authorities (ICDRA) INDIA-2024 on Wednesday, ICMR DG Dr Bahl said, "The handheld X-rays are available at a very high cost and now the IIT Kanpur in partnership with ICMR has developed a handheld X-ray indigenously which will
After the half-burnt body of an unidentified woman was found in West Bengal's Nadia district on Wednesday, the State Congress President Subhankar Sarkar said that current posted Superintendent of Police (SP) is disdainful and could project it as common incident.
New Delhi [India], October 16: Cellecor Gadgets Limited has delivered impressive growth in the first half of FY25, showcasing strong financial performance. The company reported a total revenue of INR 425.71 crore, marking a 103.05% increase compared to H1 FY24. EBITDA surged by 98.67%, reach
Ahmedabad (Gujarat) [India], October 14: Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology, immunology, and critical care therapies, announced that the U.S. Food and Drug Administration (FDA) has approved IMULDOSA (uste